Notice: trader_wma(): invalid value '1', expected a value between 2 and 100000 in /home/getagraph/public_html/AAA/app/Services/StockChartDataService.php on line 250
BridgeBio Oncology [BBOT]
Datos pivot
Estadísticas pivot
| Métrica | Promedio | Mediana | Desv. est. |
|---|---|---|---|
| Ganancia % | 20.24% | 19.95% | 7.04% |
| Pérdida % | -18.41% | -19.07% | 3.76% |
| Duración | 14.6d | 15d | 8.9d |
| Pivots encontrados | 21 |
| Tramos ganancia/pérdida | 20 (10 Ganancia / 10 Pérdida) |
| Último pivot | Bottom @ $7.12 el 2026-06-10 |
| Cambio desde el último pivot | $0.44 (6.18%) |
Predicción del próximo pivot Último: $7.50
| Próximo tipo previsto | Top |
| Precio previsto (prom.) | $8.56 |
| Precio previsto (mediana) | $8.54 |
| Rango de precio previsto (~68%) | $8.06 - $9.06 |
| Cambio al objetivo promedio | $1.06 (14.15%) |
| Fecha prevista (prom.) | 2026-06-24 |
| Rango de fechas previsto (~68%) | 2026-06-15 - 2026-07-03 |
| Base | Based on 10 historical gains (Avg: 20.24%, Median: 19.95%, StdDev: 7.04%) and duration (Avg: 14.6 days, StdDev: 8.9 days) |
| Nota | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Moderate loss for BridgeBio Oncology on Thursday.
BridgeBio Oncology (BBOT) stock price experienced a moderate pullback on Thursday after the stock fell $-0.120 (-1.56%) from the previous session on extraordinarily high volume. The stock held up slightly better than the falling NASDAQ (-2.21% down). A total of 2.29M stocks were traded yesterday, valued at $17.34M, 1.74M shares more than the previous day (557 300 shares traded). This is above the average volume for the stock at 340 825 shares traded per day.
BridgeBio Oncology signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Strong Bearish Consensus: A significant wave of negative pressure is evident across all time horizons. Technical indicators are decisively bearish in the short-term (20/30, net -66.7%), medium-term (20/30, net -66.7%), and long-term (20/30, net -66.7%), signaling a robust and sustained downtrend.
BridgeBio Oncology Support & Resistance Levels
The stock is trading above the closest support level at $7.50. approximately $0.0600 (0.79%) away. This suggests it is currently acting as a floor, pushing down towards support.The sup dis das support s17.5 -
BridgeBio Oncology Evaluation
- Corto puntuación: -5.92
- Medio puntuación: -7.21
- Largo puntuación: -7.08